Published in Law and Health Weekly, May 29th, 2004
The PMA application requests an expansion of the bridge to transplant (BTT) indication for use of the Novacor LVAS to include certain heart failure patients who are not listed for transplant due to contraindications that may resolve with LVAS support.
The application, which was originally submitted to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.